Recap of Dr. Joel Schuman's Presentation at 2025 American Glaucoma Society Meeting

Insights on VERONA Clinical Trial of EYP-1901

Wills Eye at ARVO 2025

Second-Generation Anti-VEGFs in Age-Related Macular Degeneration

Electrical Stimulation Therapy: A Promising Approach to Vision Loss in Glaucoma and Other Optic Neuropathies

CVI a leading cause of visual impairment in children but often overlooked

Phase 2 DAVIO 2 Clinical Trial Results

Impact of Prior DME Treatment on Aflibercept 8 mg Outcomes

Video: Diabetic Macular Edema Study Results

WILLS EYE GLAUCOMA LEADER RECEIVES $6.2 MILLION NIH AWARD FOR VISION RESEARCH

New Gene Therapy for Retinitis Pigmentosa Shows Promise

Wills to Present Study Results that Aid Detection of ATTR

STUDY RESULTS ON ENDOPHTHALMITIS RATES AND TYPES OF TREATMENTS AFTER INTRAOCULAR PROCEDURES

Wills Study: Post-op Endophthalmitis Rates Down Fourfold Over 20-Year Period

Wills Residents Offer Strategies for AI in Healthcare